Tumor necrosis factor inhibitors in the treatment of chronic inflammatory diseases. a review of immunogenicity and potential implications
Flood, J.
Managed Care 18(4 Suppl 3: 1-5
2009
ISSN/ISBN: 1062-3388 PMID: 19562866 Document Number: 634016
Document emailed within 1 workday
Related Documents
Girolomoni, G.; Pastore, S.; Albanesi, C.; Cavani, A. 2002: Targeting tumor necrosis factor-alpha as a potential therapy in inflammatory skin diseases Current Opinion in Investigational Drugs 3(11): 1590-1595Gorelik, E.; Begoviĉ, M.; Duty, L.; Herberman, R.B. 1991: Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor Cancer Research 51(5): 1521-1528
Schmidt, K.L. 2000: Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases Journal of Rheumatology 27(9): 2281-2282
Green, L.J..; Yamauchi, P.S..; Kircik, L.H.. 2019: Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients with Psoriasis Journal of Drugs in Dermatology: Jdd 18(8): 776-788
Kokot, T.; Muc-Wierzgoń, M.; Zubelewicz, B.; Wierzgoń, J.; Nowakowska, E.; Brodziak, A. 2000: Soluble tumor necrosis factor receptors--their properties and role in diagnosis and therapy of acute and chronic diseases Postepy Higieny i Medycyny Doswiadczalnej 54(5): 585-596
Totpal, K.; Agarwal, S.; Aggarwal, B.B. 1992: Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cells Cancer Research 52(9): 2557-2562
Kotyla, P.J.; Sliwinska-Kotyla, B.; Kucharz, E.J. 2006: Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin Journal of rheumatology 33(11): 2361-3; author reply 2363
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Tan, X.; Balkrishnan, R.; Feldman, S.R. 2013: Infections associated with the use of tumor necrosis factor-α inhibitors in psoriasis Journal of Drugs in Dermatology: Jdd 12(3): E41-E45
Bendtzen, K.; Hansen, P.R.; Rieneck, K. 2004: Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor-alpha and interferon-gamma and has potential effect in the treatment of arthritis Ugeskrift for Laeger 166(37): 3203-3207
Nelson, S.; Bagby, G.J.; Summer, W.R. 1990: Alcohol-induced suppression of tumor necrosis factor--a potential risk factor for secondary infection in the acquired immunodeficiency syndrome Progress in Clinical and Biological Research 325: 211-220
Ganesan, S.; Travis, S.P.L.; Ahmad, T.; Jazrawi, R. 2002: Therapeutic inhibitors of tumor necrosis factor in Crohn's disease Current Opinion in Investigational Drugs 3(9): 1301-1306
Cathcart, S.; Sami, N.; Elewski, B. 2012: Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors Journal of Drugs in Dermatology: Jdd 11(5): 609-612
Ho, L.; Pasinetti, G.Maria. 2001: The potential of selective COX-2 inhibitors in inflammatory and other diseases Drugs of Today 37(3): 181-185
Hori, K.; Ehrke, M.J.; Mace, K.; Mihich, E. 1987: Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon Cancer Research 47(22): 5868-5874
He, S.; Huang, H. 1997: Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis Zhonghua Nei Ke Za Zhi 36(8): 526-528
Giroir, B.P.; Peppel, K.; Silva, M.; Beutler, B. 1992: The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors European Cytokine Network 3(6): 533-538
Chen, M.; Holland, M.J.; Mir, M.R.; Wong, M.G.; Kelley, B.P.; Grim, K.D.; Bhuchar, S.S.; Hsu, S. 2011: Frequency of thrombocytopenia in psoriasis patients treated with tumor necrosis factor-a inhibitors Journal of Drugs in Dermatology: Jdd 10(3): 280-284
Weinberg, J.M.; Saini, R. 2003: Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept Cutis 71(1): 25-29